Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $7.33 which represents a decrease of $-0.20 or -2.66% from the prior close of $7.53. The stock opened at $7.64 and touched a ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifted AI-driven biotech stocks this week while boosting an unlikely winner, Metagenomi (NASDAQ:MGX), which benefitted from ...

Leerink Partnrs cut their FY2024 earnings estimates for shares of Recursion Pharmaceuticals in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now expects that ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 26,172 calls trading, 4x expected, and implied vol increasing almost 7 ...

Texas Instruments falls after the chip maker’s first-quarter earnings forecast misses estimates, and Boeing declines after ...

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth ...

Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in ...

Recursion Pharmaceuticals Inc (RXRX) stock saw a modest uptick, ending the day at $7.49 which represents a slight increase of $0.61 or 8.87% from the prior close of $6.88. The stock opened at $7.17 ...

Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...